Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-06

FDA Approved: TOBRAMYCIN INHALATION SOLUTION PAK — Supplemental Application (Genericus, Inc.)

View source ↗

Summary

FDA approved a supplemental application to authorize Genericus, Inc. to market a generic tobramycin inhalation solution PAK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN INHALATION SOLUTION PAK (TOBRAMYCIN)

Snippet

SUPPL AP for TOBRAMYCIN INHALATION SOLUTION PAK (TOBRAMYCIN)